Translational vehicles for neuroprotection

Biochemical Society Transactions

Volumn 34, Issue 6, 2006, Pages 1318-1322

  Papadakis, M ^a,b   Buchan, A M ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Animal experiment; Intracerebral haemorrhage; Neuroprotection; Neurovascular imaging; Thrombolysis; Tissue plasminogen activator (tPA)

Indexed keywords

ALTEPLASE; DISUFENTON SODIUM; GADOLINIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PADGEM PROTEIN; PLACEBO; POSTSYNAPTIC DENSITY PROTEIN 95; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SCAFFOLD PROTEIN; BENZENESULFONIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT;

ABSENCE OF SIDE EFFECTS; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CELL PROTECTION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; META ANALYSIS; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; SYSTEMATIC REVIEW; ANIMAL; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; FIBRINOLYTIC THERAPY; PROTEIN SYNTHESIS; REVIEW;

ANIMALIA;

ANIMALS; BENZENESULFONATES; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; HUMANS; NEUROPROTECTIVE AGENTS; PROTEIN BIOSYNTHESIS; THROMBOLYTIC THERAPY;

EID: 34248684144     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0341318     Document Type: Conference Paper

References (40)

1. Baird, A.E. and Warach, S. (1998) J. Cereb. Blood Flow Metab. 18, 583-609
2. Butcher, K.S., Parsons, M., MacGregor, L., Barber, P.A., Chalk, J., Bladin, C., Levi, C., Kimber, T., Schultz, D., Fink, J. et al. (2005) Stroke 36, 1153-1159
3. Wardlaw, J.M., del, Z.G. and Yamaguchi, T. (2000) Cochrane Database Syst. Rev. 2, D000213
4. del Zoppo, G.J., Poeck, K., Pessin, M.S., Wolpert, S.M., Furlan, A.J., Ferbert, A., Alberts, M.J., Zivin, J.A., Wechsler, L., Busse, O. et al. (1992) Ann. Neurol. 32, 78-86
5. Hill, M.D. and Buchan, A.M. (2005) Can. Med. Assoc. J. 172, 1307-1312
6. Barber, P.A., Demchuk, A.M., Zhang, J. and Buchan, A.M. (2000) Lancet 355, 1670-1674
7. del Zoppo, G.J., Higashida, R.T., Furlan, A.J., Pessin, M.S., Rowley, H.A. and Gent, M. (1998) Stroke 29, 4-11
8. Ferro, J.M. (2006) J. Neurol. 253, 985-999
9. Lampl, Y., Gilad, R., Eshel, Y. and Sarova-Pinhas, I. (1995) Stroke 26, 2249-2253
10. Mendelow, A.D., Gregson, B.A., Fernandes, H.M., Murray, G.D., Teasdale, G.M., Hope, D.T., Karimi, A., Shaw, M.D. and Barer, D.H. (2005) Lancet 365, 387-397
11. Mayer, S.A., Brun, N.C., Begtrup, K., Broderick, J., Davis, S., Diringer, M.N., Skolnick, B.E. and Steiner, T. (2005) New Engl. J. Med. 352, 777-785
12. Monroe, D.M., Hoffman, M., Oliver, J.A. and Roberts, H.R. (1997) Br. J. Haematol. 99, 542-547
13. Hoffman, M. and Monroe, III, D.M. (2001) Thromb. Haemostasis 85, 958-965
14. Lipton, P. (1999) Physiol. Rev. 79, 1431-1568
15. Newell, D.W., Barth, A., Papermaster, V. and Malouf, A.T. (1995) J. Neurosci. 15, 7702-7711
16. Pulsinelli, W.A., Brierley, J.B. and Plum, F. (1982) Ann. Neurol. 11, 491-498
17. Buchan, A., Li, H. and Pulsinelli, W.A. (1991) J. Neurosci. 11, 1049-1056
18. Buchan, A.M., Slivka, A. and Xue, D. (1992) Brain Res. 574, 171-177
19. Cimino, M., Balduini, W., Carloni, S., Gelosa, P., Guerrini, U., Tremoli, E. and Sironi, L. (2005) Neurotoxicology 26, 929-933
20. Arundine, M. and Tymianski, M. (2003) Cell Calcium 34, 325-337
21. Horn, J., de Haan, R.J., Vermeulen, M., Luiten, P.G. and Limburg, M. (2001) Stroke 32, 2433-2438
22. Aarts, M., Iihara, K., Wei, W.L., Xiong, Z.G., Arundine, M., Cerwinski, W., MacDonald, J.F. and Tymianski, M. (2003) Cell 115, 863-877
23. Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J.W., Wang, Y.T., Salter, M.W. and Tymianski, M. (2002) Science 298, 846-850
24. Prunell, G.F., Arboleda, V.A. and Troy, C.M. (2005) Curr. Drug Targets CNS Neurol. Disord. 4, 51-61
25. Green, A.R., Ashwood, T., Odergren, T. and Jackson, D.M. (2003) Pharmacol. Ther. 100, 195-214
26. Pryor, W.A., Terauchi, K. and Davis, Jr, W.H. (1976) Environ. Health Perspect. 16, 161-176
27. Dehouck, M.P., Cecchelli, R., Richard, G.A., Renftel, M. and Lundquist, S. (2002) Brain Res. 955, 229-235
28. Kuroda, S., Tsuchidate, R., Smith, M.L., Maples, K.R. and Siesjo, B.K. (1999) J. Cereb. Blood Flow Metab. 19, 778-787
29. Sydserff, S.G., Borelli, A.R., Green, A.R. and Cross, A.J. (2002) Br. J. Pharmacol. 135, 103-112
30. Marshall, J.W., Duffin, K.J., Green, A.R. and Ridley, R.M. (2001) Stroke 32, 190-198
31. Marshall, J.W., Cummings, R.M., Bowes, L.J., Ridley, R.M. and Green, A.R. (2003) Stroke 34, 2228-2233
32. Lees, K.R., Barer, D., Ford, G.A., Hacke, W., Kostulas, V., Sharma, A.K. and Odergren, T. (2003) Stroke 34, 482-487
33. Lees, K.R., Zivin, J.A., Ashwood, T., Davalos, A., Davis, S.M., Diener, H.C., Grotta, J., Lyden, P., Shuaib, A., Hardemark, H.G. and Wasiewski, W.W. (2006) New Engl. J. Med. 354, 588-600
34. He, G., Samouilov, A., Kuppusamy, P. and Zweier, J.L. (2002) Mol. Cell. Biochem. 234-235, 359-367
35. Marklund, N., Lewander, T., Clausen, F. and Hillered, L. (2001) J. Cereb. Blood Flow Metab. 21, 1259-1267
36. Yoshimura, T., Yokoyama, H., Fujii, S., Takayama, F., Oikawa, K. and Kamada, H. (1996) Nat. Biotechnol. 14, 992-994
37. Fujii, S., Suzuki, Y., Yoshimura, T. and Kamada, H. (1998) Am. J. Physiol. 274, G857-G862
38. Higuchi, T., Fernandez, E.J., Maudsley, A.A., Shimizu, H., Weiner, M.W. and Weinstein, P.R. (1996) Neurosurgery 38, 121-129
39. Schurr, A. (2002) Int. J. Mol. Med. 10, 131-136
40. Barber, P.A., Foniok, T., Kirk, D., Buchan, A.M., Laurent, S., Boutry, S., Muller, R.N., Hoyte, L., Tomanek, B. and Tuor, U.I. (2004) Ann. Neurol. 56, 116-120